Conjugated estrogens/trimegestone - Wyeth
Alternative Names: Premarin®/Trimegestone; Trimegestone/conjugated estrogens; Trimegestone/Premarin®Latest Information Update: 16 Jul 2009
At a glance
- Originator Astellas Pharma; Wyeth
- Developer Wyeth
- Class Estradiol congeners; Norpregnadienes; Osteoporosis therapies
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Menopausal syndrome; Postmenopausal osteoporosis
Most Recent Events
- 31 Dec 2001 Phase-III clinical trials in Postmenopausal osteoporosis in USA (PO)
- 31 Aug 2001 Phase-III clinical trials in Menopausal syndrome in USA (PO)